Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chung Man Ho

Showing results (41-50 of 120) with videos related to

Pageof 12
Sort By:
Anti-Cancer Drugs|August 10, 2022
Association of genetic polymorphisms of CYP3A4 and CYP2D6 with gefitinib-induced toxicitiesWang Chun Kwok, David Chi Leung Lam, Mary Sau Man Ip, et al.
Thoracic Cancer|June 7, 2022
Survival benefits from afatinib compared with gefitinib and erlotinib among patients with common EGFR mutation in first-line settingWang Chun Kwok, James Chung Man Ho, Terence Chi Chun Tam, et al.
Journal of Thoracic Disease|July 11, 2022
Serum protein level as a predictor of therapeutic response and adverse effects associated with afatinib useWang Chun Kwok, James Chung Man Ho, Terence Chi Chun Tam, et al.
Respiratory Research|April 29, 2021
Risk factors for Pseudomonas aeruginosa colonization in non-cystic fibrosis bronchiectasis and clinical implicationsWang Chun Kwok, James Chung Man Ho, Terence Chi Chun Tam, et al.
European Clinical Respiratory Journal|July 1, 2024
Baseline neutrophil-to-lymphocyte ratio as a predictor of response to hospitalized bronchiectasis exacerbation risksWang Chun Kwok, James Chung Man Ho, David Chi Leung Lam, et al.
Journal of Thoracic Disease|June 17, 2024
Systemic immune-inflammation index in predicting hospitalized bronchiectasis exacerbation risks and disease severityWang Chun Kwok, Terence Chi Chun Tam, David Chi Leung Lam, et al.
Allergy, Asthma & Immunology Research|November 10, 2016
Development and Validation of an Attitudinal-Profiling Tool for Patients With AsthmaAileen David-Wang, David Price, Sang Heon Cho, et al.
International Journal of Oncology|April 3, 2014
Downregulation of thymidylate synthase with arsenic trioxide in lung adenocarcinomaSze-Kwan Lam, Judith Choi-Wo Mak, Chun-Yan Zheng, et al.
Lung Cancer (Amsterdam, Netherlands)|September 18, 2013
Combination of arsenic trioxide and chemotherapy in small cell lung cancerChun-yan Zheng, Sze-kwan Lam, Yuan-yuan Li, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|May 6, 2014
A systematic review and meta-analysis of herbal medicine on chronic obstructive pulmonary diseasesHai Yong Chen, Chun Ho Ma, Ke-Jian Cao, et al.
Pageof 12

Showing results (41-50 of 120) with videos related to

Sort By:
Pageof 12
Anti-Cancer Drugs|August 10, 2022
Association of genetic polymorphisms of CYP3A4 and CYP2D6 with gefitinib-induced toxicitiesWang Chun Kwok, David Chi Leung Lam, Mary Sau Man Ip, et al.
Thoracic Cancer|June 7, 2022
Survival benefits from afatinib compared with gefitinib and erlotinib among patients with common EGFR mutation in first-line settingWang Chun Kwok, James Chung Man Ho, Terence Chi Chun Tam, et al.
Journal of Thoracic Disease|July 11, 2022
Serum protein level as a predictor of therapeutic response and adverse effects associated with afatinib useWang Chun Kwok, James Chung Man Ho, Terence Chi Chun Tam, et al.
Respiratory Research|April 29, 2021
Risk factors for Pseudomonas aeruginosa colonization in non-cystic fibrosis bronchiectasis and clinical implicationsWang Chun Kwok, James Chung Man Ho, Terence Chi Chun Tam, et al.
European Clinical Respiratory Journal|July 1, 2024
Baseline neutrophil-to-lymphocyte ratio as a predictor of response to hospitalized bronchiectasis exacerbation risksWang Chun Kwok, James Chung Man Ho, David Chi Leung Lam, et al.
Journal of Thoracic Disease|June 17, 2024
Systemic immune-inflammation index in predicting hospitalized bronchiectasis exacerbation risks and disease severityWang Chun Kwok, Terence Chi Chun Tam, David Chi Leung Lam, et al.
Allergy, Asthma & Immunology Research|November 10, 2016
Development and Validation of an Attitudinal-Profiling Tool for Patients With AsthmaAileen David-Wang, David Price, Sang Heon Cho, et al.
International Journal of Oncology|April 3, 2014
Downregulation of thymidylate synthase with arsenic trioxide in lung adenocarcinomaSze-Kwan Lam, Judith Choi-Wo Mak, Chun-Yan Zheng, et al.
Lung Cancer (Amsterdam, Netherlands)|September 18, 2013
Combination of arsenic trioxide and chemotherapy in small cell lung cancerChun-yan Zheng, Sze-kwan Lam, Yuan-yuan Li, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|May 6, 2014
A systematic review and meta-analysis of herbal medicine on chronic obstructive pulmonary diseasesHai Yong Chen, Chun Ho Ma, Ke-Jian Cao, et al.
Pageof 12